ACR appropriateness Criteria® pediatric Hodgkin lymphoma-Reference-Cited by-同舟云学术

ACR appropriateness Criteria® pediatric Hodgkin lymphoma

Published:2014-02-24 Issue:7 Volume:61 Page:1305-1312
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Terezakis Stephanie A.¹,Metzger Monika L.²,Hodgson David C.³,Schwartz Cindy L.⁴,Advani Ranjana⁵,Flowers Christopher R.⁶,Hoppe Bradford S.⁷,Ng Andrea⁸,Roberts Kenneth B.⁹,Shapiro Ronald¹⁰,Wilder Richard B.¹¹^ORCID,Yunes Michael J.¹²,Constine Louis S.¹³

Affiliation:

1. Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Hospital; Baltimore Maryland

2. St. Jude Children's Research Hospital; Memphis, Tennessee, American Society of Clinical Oncology; Alexandria Virginia

3. Princess Margaret Hospital; Toronto Ontario Canada

4. MD Anderson Cancer Center; Houston Texas

5. Stanford Cancer Center, Stanford; California, American Society of Clinical Oncology; Alexandria Virginia

6. Emory University, Atlanta, Georgia; American Society of Clinical Oncology; Alexandria Virginia

7. University of Florida Proton Therapy Institute; Jacksonville Florida

8. Harvard University; Boston Massachusetts

9. Yale University School of Medicine; New Haven Connecticut

10. Indiana University School of Medicine; Indianapolis Indiana

11. Moffitt Cancer Center; Tampa Florida

12. Baystate Medical Center and Tufts University School of Medicine; Springfield Massachusetts

13. University of Rochester Medical Center; Rochester New York

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Reference45 articles.

1. Pediatric hodgkin lymphoma: Maximizing efficacy and minimizing toxicity;Hodgson;Semin Radiat Oncol,2007

2. The balance between cure and late effects in childhood Hodgkin's lymphoma: The experience of the German-Austrian Study-Group since 1978. German-Austrian Pediatric Hodgkin's Disease Study Group;Schellong;Ann Oncol,1996

3. Concordance for Hodgkin's disease in identical twins suggesting genetic susceptibility to the young-adult form of the disease;Mack;N Engl J Med,1995

4. Epstein-Barr virus in pediatric Hodgkin disease: Age and histiotype are more predictive than geographic region;Razzouk;Med Pediatr Oncol,1997

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Retrospective single-center experience with OEPA/COPDAC and PET-CT based strategy for pediatric Hodgkin lymphoma in a LMIC setting;Pediatric Hematology and Oncology;2022-03-10

2. Oncology of Childhood and Adolescence;Reference Module in Biomedical Sciences;2021

3. InPOG-HL-15-01 - Challenges and lessons learnt in setting up the first collaborative multicentre prospective clinical trial in childhood cancer in India;Pediatric Hematology Oncology Journal;2020-10

4. Hodgkin Lymphoma in Children and Adolescents: Advances in Pathology, Diagnosis, and Treatment Strategies;Indian Journal of Medical and Paediatric Oncology;2020-07

5. Autologous hematopoietic cell transplantation for the treatment of relapsed/refractory pediatric, adolescent, and young adult Hodgkin lymphoma: a single institutional experience;Bone Marrow Transplantation;2020-04-09